Stem cells for the treatment of neurological disorders

@article{Lindvall2006StemCF,
  title={Stem cells for the treatment of neurological disorders},
  author={Olle Lindvall and Zaal Kokaia},
  journal={Nature},
  year={2006},
  volume={441},
  pages={1094-1096}
}
Many common neurological disorders, such as Parkinson's disease, stroke and multiple sclerosis, are caused by a loss of neurons and glial cells. In recent years, neurons and glia have been generated successfully from stem cells in culture, fuelling efforts to develop stem-cell-based transplantation therapies for human patients. More recently, efforts have been extended to stimulating the formation and preventing the death of neurons and glial cells produced by endogenous stem cells within the… 

Stem Cell Transplantation in Neurological Diseases

TLDR
The potential of various cell therapies in childhood neurological diseases are discussed and stem-cell-based transplantation therapies for human neurological diseases, such as Parkinson disease, stroke or neuromuscular disorders are discussed.

Human Neural Stem Cell Transplants in Neurological Disorders: Current Trends and Future Options

TLDR
During the past decade, cell replacement therapy, gene transfer, and selective repair of injured neural cells in diseased areas of human brain and experimental animal models have become active areas of research with potential for promising therapeutic developments in neurological diseases.

Stem cell‐based cell therapy in neurological diseases: A review

TLDR
Steady and solid progress in stem cell research in both basic and preclinical settings should support the hope for development of stem cell‐based cell therapies for neurological diseases.

Stem cell transplantation therapy in Parkinson’s disease

TLDR
It is hoped this review may provide suggestions for viable strategies to overcome the current technical and biological issues associated with the application of stem cells in Parkinson’s disease.

Regenerative Medicine in the Central Nervous System: Stem Cell-Based Gene-Therapy

TLDR
Steady and solid progress in stem cell research in both basic and pre-clinical settings should support the hope for development of stem cell-based cell therapies for neurological diseases.

Regenerative Medicine in the Central Nervous System: Stem Cell-Based Cell- and Gene-Therapy

TLDR
Steady and stepwise progress in stem cell research in both basic and pre-clinical settings should support the hope for development of stem cell-based therapies for neurodegenerative diseases.

Stem cell therapy for neurological disorders

TLDR
A review of the current strategies of stem-cell based therapy for some of the more common neurological disorders is given, discussing the progress and current challenges, and giving an overview of future perspectives.

Human Neural Stem Cell-Based Cell- and Gene-Therapy for Neurological Diseases

TLDR
Steady and stepwise progress in stem cell research in both basic and pre-clinical settings should support the hope for development of stem cell-based therapies for neurodegenerative diseases.

The changing face of neural stem cell therapy in neurologic diseases.

TLDR
Recent data regarding their beneficial effects in various animal models of neurologic diseases indicate that transplanted NSCs may also attenuate deleterious inflammation, protect the central nervous system from degeneration, and enhance endogenous recovery processes.

The role of stem cells in Parkinson's disease.

...

References

SHOWING 1-10 OF 35 REFERENCES

Stem cell therapy for human neurodegenerative disorders–how to make it work

TLDR
Findings raise hope for the development of stem cell therapies in human neurodegenerative disorders and need to know much more about how to control stem cell proliferation and differentiation into specific phenotypes, induce their integration into existing neural and synaptic circuits, and optimize functional recovery in animal models closely resembling the human disease.

GDNF delivery using human neural progenitor cells in a rat model of ALS.

TLDR
It is concluded that genetically modified hNPC can survive, integrate, and release GDNF in the spinal cord of SOD1 (G93A) rats, which provide an interesting source of cells for both glial replacement and trophic factor delivery in future human clinical studies.

Persistent Production of Neurons from Adult Brain Stem Cells During Recovery after Stroke

TLDR
It is shown that endogenous neural stem cells continuously supply the injured adult brain with new neurons, which suggests novel self‐repair strategies to improve recovery after stroke.

Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.

TLDR
It is demonstrated that FGF20, preferentially expressed in the substantia nigra, acts synergistically with FGF2 to increase the number of DA neurons in ES cell-derived neurospheres, and that the transplanted cells functioned as DA neurons and attenuated MPTP-induced neurological symptoms.

Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis

TLDR
Adult neural precursor cells promote multifocal remyelination and functional recovery after intravenous or intrathecal injection in a chronic model of multiple sclerosis, both clinically and neurophysiologically.

Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism

TLDR
The results indicate that undifferentiated adult NPCs have relevant therapeutic potential in chronic inflammatory CNS disorders because they display immune-like functions that promote long-lasting neuroprotection.

Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates

Glial cell line-derived neurotrophic factor (GDNF) has been shown to increase the survival and functioning of dopamine neurons in a variety of animal models and some recent human trials. However,

Derivation of midbrain dopamine neurons from human embryonic stem cells.

  • A. PerrierV. Tabar L. Studer
  • Biology, Chemistry
    Proceedings of the National Academy of Sciences of the United States of America
  • 2004
TLDR
Conditions to direct hES cells into neurons of midbrain dopaminergic identity are described and high-yield DA neuron derivation was confirmed from three independent hES and two monkey embryonic stem cell lines.

Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice.

We report that prospectively isolated, human CNS stem cells grown as neurospheres (hCNS-SCns) survive, migrate, and express differentiation markers for neurons and oligodendrocytes after long-term